pravastatin has been researched along with Acute-Phase Reaction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, G; Fan, D; Han, G; Li, H; Li, R; Liu, D; Liu, Q; Song, C; Tao, L; Zhang, M | 1 |
| Fang, CH; Li, JJ | 1 |
1 trial(s) available for pravastatin and Acute-Phase Reaction
| Article | Year |
|---|---|
Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial.
Topics: Acute-Phase Reaction; Female; Humans; Meta-Analysis as Topic; Osteoporosis; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid | 2022 |
1 other study(ies) available for pravastatin and Acute-Phase Reaction
| Article | Year |
|---|---|
C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
Topics: Acute-Phase Reaction; Aspirin; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Heptanoic Acids; Humans; Incidence; Inflammation; Interleukin-6; Lovastatin; Pravastatin; Predictive Value of Tests; Pyrroles; Risk Factors; Simvastatin | 2004 |